CLEC12A-CLEC2A Fusion FISH Probe
The CLEC12A-CLEC2A Fusion FISH Probe is used to confirm a fusion of the CLEC12A and CLEC2A genes. The fusion of the CLEC12A and CLEC2A genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CLEC12A-CLEC2A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CLEC12A-CLEC2A-20-AQAQ | 20 (40 μL) | 200 μL |
|
CLEC12A Gene Summary
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signaling, glycoprotein turnover, and roles in inflammation and immune response. The protein encoded by this gene is a negative regulator of granulocyte and monocyte function. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. This gene is closely linked to other CTL/CTLD superfamily members in the natural killer gene complex region on chromosome 12p13. [provided by RefSeq, May 2011]
Gene Name: C-type Lectin Domain Family 12 Member A
Chromosome: CHR12: 10103914 -10138194
Locus: 12p13.31
CLEC2A Gene Summary
CLEC2A belongs to the CLEC2 family of activation-induced, natural killer gene complex-encoded C-type lectin-like receptors (Spreu et al., 2007 [PubMed 18046548]).[supplied by OMIM, May 2008]
Gene Name: C-type Lectin Domain Family 2 Member A
Chromosome: CHR12: 10065825 -10084980
Locus: 12p13.31
Gene Diseases
The CLEC12A CLEC2A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|